Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Long-Term Deferred Tax (2017 - 2024)

Historic Long-Term Deferred Tax for Dianthus Therapeutics (DNTH) over the last 2 years, with Q4 2024 value amounting to $21.7 million.

  • Dianthus Therapeutics' Long-Term Deferred Tax changed N/A to $21.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $21.7 million, marking a year-over-year change of. This contributed to the annual value of $21.7 million for FY2024, which is N/A changed from last year.
  • Dianthus Therapeutics' Long-Term Deferred Tax amounted to $21.7 million in Q4 2024.
  • In the past 5 years, Dianthus Therapeutics' Long-Term Deferred Tax ranged from a high of $21.7 million in Q4 2024 and a low of $21.7 million during Q4 2024